大動脈弁狭窄症市場：種類別、大動脈弁の種類別、重症度別、エンドユーザー別、地域別

大動脈弁狭窄症市場は、2025年に101億7,000万米ドルと推定され、2032年には204億6,000万米ドルに達すると予測され、2025年から2032年までのCAGRは10.5%で成長する見込みです。

大動脈弁狭窄症は、左心室と大動脈を隔てる大動脈弁口の狭窄です。心臓から主動脈（大動脈）への血流を阻害し、心臓の主ポンプ室の収縮ごとに身体に送り出される血液量を減少させる。大動脈弁狭窄症の進行は何年もかけてゆっくりと起こり、初期には無症状ですが、重度になるにつれて症状が現れます。弁口がさらに狭くなると、制限された弁口から十分な血液を送り出すために心臓はより強く働かなければならず、心臓に余分な負担がかかります。このため、治療を行わなければ、最終的には心筋が弱り、損傷する可能性があります。

市場力学

高血圧、肥満、糖尿病などの危険因子の有病率の上昇が、世界の大動脈弁狭窄症市場の成長に大きく寄与しています。大動脈弁狭窄症の一般的な原因には、加齢、大動脈弁にカルシウムが沈着して硬くなること、リウマチ熱、大動脈弁の先天奇形などがあります。高齢化、技術の進歩、認知度の向上が、予測期間中の世界の大動脈弁狭窄症市場の成長を促進すると予想されます。さらに医療費の増加も、予測期間における世界の大動脈弁狭窄症市場の成長を後押しすると予想されます。経カテーテル的大動脈弁置換術（TAVR）の拡大、新興国市場での治療や新薬開発、個別化医療、遠隔医療や遠隔モニタリングは、予測期間中に世界の大動脈弁狭窄症市場に成長機会をもたらすと期待されています。

しかし、高額な治療費、限定的な償還政策、入手可能性と認知度の障壁、臨床的および手技的合併症が、予測期間中の大動脈弁狭窄症市場の成長を妨げると予想されます。

当レポートの主な特徴

• 当レポートは、世界の大動脈弁狭窄症市場を詳細に分析し、2024年を基準年とした予測期間（2025～2032年）の市場規模・CAGRを掲載しています。
• また、各セグメントの潜在的な収益機会を明らかにし、この市場の魅力的な投資提案のマトリックスについて説明しています。
• また、市場の促進要因・抑制要因や機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
• 世界の大動脈弁狭窄症市場における主要企業プロファイルを、企業概要、製品ポートフォリオ、主要なハイライト、財務実績、戦略などの以下のパラメータに基づいて掲載しています。
• 当レポートの洞察を用いて、マーケティング担当者や企業の経営陣が、将来の製品発売・提携・市場拡大・マーケティング戦術に関する、十分な情報に基づいた意思決定を下すことができます。
• 世界の大動脈弁狭窄症市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界のさまざまな利害関係者に対応しています。
• 利害関係者は、世界の大動脈弁狭窄症市場の分析に使用される様々な戦略マトリックスを通じて、意思決定を容易にすることができます。

目次

第1章 分析目的と前提条件

• 分析目的
• 前提条件
• 略語

第2章 市場の展望

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー
• Coherent Opportunity Map (COM)

第3章 市場力学・規制・動向の分析

• 市場力学
  • 高齢化人口
  • 高額な治療費
  • 経カテーテル大動脈弁置換術（TAVR）の拡張
• 影響分析
• 主なハイライト
• 規制シナリオ
• 製品の発売/承認
• PEST分析
• パイプライン分析
• ポーターのファイブフォース分析
• 企業合併・買収 (M&A) のシナリオ

第4章 世界の大動脈弁狭窄症市場：新型コロナウイルス感染症 (COVID-19) パンデミックの影響

• COVID-19の疫学
• 供給側と需要側の分析
• 経済への影響

第5章 世界の大動脈弁狭窄症市場：種類別（2020～2032年）

• 先天性大動脈弁狭窄症
• 後天性大動脈弁狭窄症

第6章 世界の大動脈弁狭窄症市場：大動脈弁の種類別（2020～2032年）

• 機械式大動脈弁
• 生体弁（組織弁）大動脈弁

第7章 世界の大動脈弁狭窄症市場：重症度別（2020～2032年）

• 軽度大動脈弁狭窄症
• 中度大動脈弁狭窄症
• 重度大動脈弁狭窄症

第8章 世界の大動脈弁狭窄症市場：エンドユーザー別（2020～2032年）

• 病院
• クリニック
• 外来手術センター
• その他

第9章 世界の大動脈弁狭窄症市場：地域別（2020～2032年）

• 北米
• 米国
• カナダ
• レインアメリカ
• ブラジル
• メキシコ
• アルゼンチン
• その他ラテンアメリカ
• 欧州
• 英国
• ドイツ
• フランス
• イタリア
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• 中国
• インド
• 日本
• オーストラリア
• 韓国
• ASEAN
• その他アジア太平洋
• 中東
• GCC
• イスラエル
• その他中東
• アフリカ
• 北アフリカ
• 中央アフリカ
• 南アフリカ

第10章 競合情勢

• Edwards Lifesciences Corporation
• Medtronic plc
• Abbott Laboratories
• Boston Scientific Corporation
• LivaNova PLC
• CryoLife, Inc
• Braile Biomedica
• JenaValve Technology, Inc
• Meril Life Sciences Pvt. Ltd
• Micro Interventional Devices, Inc
• egnite, Inc.

第11章 セクション

• 分析手法
• 出版社について

Aortic Stenosis Market is estimated to be valued at USD 10.17 Bn in 2025 and is expected to reach USD 20.46 Bn by 2032, growing at a compound annual growth rate (CAGR) of 10.5% from 2025 to 2032.

Aortic stenosis is a narrowing of the aortic valve opening that divides the left ventricle from the aorta. It obstructs the blood flow from the heart into the main artery (aorta) and reduces the amount of blood pumped out to the body with each contraction of the heart's main pumping chamber. Aortic stenosis progression can occur slowly over many years and asymptomatic in early stages, with symptoms developing as it becomes more severe. As the valve opening narrows further, the heart must work harder to pump enough blood through the restricted opening, putting extra strain on the heart. This can eventually weaken and damage the heart muscle if not treated.

Market Dynamics

The rising prevalence of risk factors such as high blood pressure, obesity and diabetes is significantly contributing to the growth of the global aortic stenosis market. Some of the common causes of aortic stenosis include aging, deposits of calcium on the aortic valve which makes it stiff, rheumatic fever and congenital malformations of the aortic valve. Aging population, technological advancements, and increasing awareness are anticipated to drive growth of the global aortic stenosis market over the forecast period. Moreover, rising healthcare expenditure is also expected to boost the growth of the global aortic stenosis market over the forecast period. Transcatheter aortic valve replacement (TAVR) expansion, emerging therapies and novel drug development, personalized medicine, and telemedicine and remote monitoring are expected to create growth opportunities for the global aortic stenosis market during the forecast period.

However, high cost of treatment, limited reimbursement policies, availability and awareness barriers, and clinical and procedural complications are expected to hamper growth of the aortic stenosis market over the forecast period.

Key features of the study:

• This report provides an in-depth analysis of the global aortic stenosis market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global aortic stenosis market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Edwards Lifesciences Corporation, Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, LivaNova PLC, CryoLife, Inc., Braile Biomedica, JenaValve Technology, Inc., Meril Life Sciences Pvt. Ltd., Micro Interventional Devices, Inc., and egnite, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global aortic stenosis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global aortic stenosis market

Aortic Stenosis Market Detailed Segmentation:

• By Type:
  • Congenital Aortic Stenosis
  • Acquired Aortic Stenosis
• By Aortic Valve Types:
  • Mechanical Aortic Valves
  • Bioprosthetic (Tissue) Aortic Valves
• By Severity:
  • Mild Aortic Stenosis
  • Moderate Aortic Stenosis
  • Severe Aortic Stenosis
• By End User:
  • Hospital
  • Clinics
  • Ambulatory Surgical Centers
  • Others
• By Region:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profile:
  • Edwards Lifesciences Corporation
  • Medtronic plc
  • Abbott Laboratories
  • Boston Scientific Corporation
  • LivaNova PLC
  • CryoLife, Inc.
  • Braile Biomedica
  • JenaValve Technology, Inc.
  • Meril Life Sciences Pvt. Ltd.
  • Micro Interventional Devices, Inc.
  • gnite, Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Type
  • Market Snapshot, By Aortic Valve Types
  • Market Snapshot, By Severity
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Aging Population
  • High Cost of Treatment
  • Transcatheter Aortic Valve Replacement (TAVR) Expansion
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• Pipeline Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Aortic Stenosis Market- Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Aortic Stenosis Market, By Type, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021- 2032
  • Segment Trends
• Congenital Aortic Stenosis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Acquired Aortic Stenosis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

6. Global Aortic Stenosis Market, By Aortic Valve Types, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Mechanical Aortic Valves
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Bioprosthetic (Tissue) Aortic Valves
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

7. Global Aortic Stenosis Market, By Severity, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Mild Aortic Stenosis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Moderate Aortic Stenosis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Severe Aortic Stenosis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

8. Global Aortic Stenosis Market, By End User, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospital
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Ambulatory Surgical Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

9. Global Aortic Stenosis Market, By Region, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, By Country, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Country 2021-2028
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Aortic Valve Types, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Severity 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2020 - 2032, (US$ Bn)
• U.S.
• Canada
• Lain America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Aortic Valve Types, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Severity 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2020 - 2028, (US$ Bn)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Aortic Valve Types, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2020 - 2032, (US$ Bn)
• U.K.
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Aortic Valve Types, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Severity 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2020 - 2032, (US$ Bn)
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Aortic Valve Types, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Severity 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2020 - 2032, (US$ Bn)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Aortic Valve Types, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Severity 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2020 - 2032, (US$ Bn)
• North Africa
• Central Africa
• South Africa

10. Competitive Landscape

• Edwards Lifesciences Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Medtronic plc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Abbott Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Boston Scientific Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• LivaNova PLC
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• CryoLife, Inc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Braile Biomedica
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• JenaValve Technology, Inc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Meril Life Sciences Pvt. Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Micro Interventional Devices, Inc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• egnite, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

11. Section

• Research Methodology
• About us